Read Time:22 Second
Public release date: 12-Sep-2007
(updated 2004 figure’s)
Lipitor – 9 Billion
Zocor – 4.7 Billion
Nexium – 4.2 Billion
Prevacid – 2.4 Billion
Zoloft – 1.9 Billion
Plavix – 1.7 Billion
Norvasc – 1.5 Billion
The survey also excluded drugs that are administered in a doctor’s office or hospital, such as cancer drugs.
The full survey is available at http://www.meps.ahrq.gov/mepsweb/data_files/publications/st180/s tat180.pdf.